Browse School of Medicine | Stanford Profiles

Masataka Wada

Postdoctoral Scholar, Psychiatry

BioDr. Masataka (he/him/his) is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.

His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Masataka is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.

Dr. Masataka's scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field.

Contact Info
mwada@stanford.edu

Quinn Waeiss

Postdoctoral Scholar, Biomedical Ethics

Contact Info
waeiss@stanford.edu

Emma Wagner

Postdoctoral Scholar, General Surgery

Contact Info
Mail Code: 5148
ew502@stanford.edu

Viktoria Philine Wagner

Postdoctoral Scholar, Neurology and Neurological Sciences

Contact Info
Mail Code: 5235
vpwagner@stanford.edu

Jen Wahleithner

Postdoctoral Scholar, Psychiatry

Contact Info
Mail Code: 5717
jenwahle@stanford.edu

Ben Waldman

Postdoctoral Scholar, Microbiology and Immunology

Contact Info
Mail Code: 5124
bwaldman@stanford.edu

Grzegorz Walkiewicz

Postdoctoral Scholar, Ophthalmology

BioGrzegorz (Greg) Walkiewicz, PhD, is a neuroscientist with a strong background in retinal and neurodegenerative disease research. He completed his PhD at KU Leuven (Belgium), focusing on tau pathology and Alzheimer’s disease. His research explores the connection between brain and eye pathology, with particular interest in pTau, Aβ, and microglial activation. He has worked extensively with transgenic mouse models as well as human brain and retinal tissues. He recently joined Stanford University to investigate INPP5K-related mechanisms in retinal ganglion cell degeneration.